DiscoverElevate Medical Affairs Podcast Channel
Elevate Medical Affairs Podcast Channel
Claim Ownership

Elevate Medical Affairs Podcast Channel

Author: Medical Affairs Professional Society

Subscribed: 6Played: 44
Share

Description

Podcast channel for the Medical Affairs Professional Society (MAPS). Global excellence in Medical Affairs from today's leaders.
43 Episodes
Reverse
In this second podcast on the EUMDR, panelists John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes - Spine | Johnson & Johnson Medical Devices Companies welcomes Philip Desjardins, JD, Vice President, Global Regulatory Affairs Spine and Medical Device Regulatory Policy, DePuy Synthes | Johnson & Johnson Medical Devices Companies, and Drilon Saliu, PharmD, MBA, Head, Medical, Clinical and HEOR, Connected Care, Philips, continue their comprehensive discussion of: Covid’s impact on EUMDR; USFDA and EUMDR global regulator comparison; short and long term impacts; how Brexit might impact the UK’s regulatory oversight; the importance of investing in top talent; new capabilities that are required; the importance of leading with influence; and, evidentiary compliance planning and budget impact.
It's sometimes challenging to find insights that are actionable in development. In this podcast, Iris Loew-Friendish, UCB Chief Medical Officer and member of the UCB Executive Committee and UCB Head of Development in Medical Practice, highlights her personal journey to help you understand how Medical Affairs is uniquely suited to address these issues.
It's sometimes challenging to find insights that are actionable in development. In this podcast, Prof. Dr. med. Iris Loew-Friedrich, UCB Chief Medical Officer and member of the UCB Executive Committee and UCB Head of Development in Medical Practice, highlights her personal journey to help you understand how Medical Affairs is uniquely suited to address these issues.
In theory, successfully commercializing a product is straightforward; in reality it is not. In this comprehensive discussion, Matthew McLoughlin, MD, ex-Head of Advisory Services and Head of the Executive Committee for Kinapse is joined by Gustavo Kesselring MD, current Academy Vice President for the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) to discuss evidence generation to meet the needs of external stakeholders, the ability to bring actionable insights into the company, and the need for revamping of knowledge acquisition. 
Patients want the best medicine and therapy available. Merinke Kuiper-Lenters, MD, a physician and patient who was diagnosed with autoimmune vasculitis, explains patient expectations from the pharma industry. 
What does the future of MA look like from a commercial perspective? Robert "Bobby" Mulrooney, MD, General Manager, UK & Ireland for Portola Pharmaceuticals, shares his candid opinions as to how MA can be a driver of strategy with commercial partners.
How can global leaders set affiliates up for success? Charlotte Kremer MD MBA, EVP of Medical Affairs for Astellas, and current MAPS President, speaks to the importance of sharing information in real time.
Host Robin Winter-Sperry MD, Head of Global Field Based Medical Excellence & Insights at Sanofi Genzyme introduces Donna Holder PharmD, Executive Director, Global Field Medical Center of Excellence (CoE) at Merck, and Ralph Rewers PharmD, AbbVie’s Global Head, Field Medical Excellence who organized this specialized course that is being offered at the MAPS annual meeting on March 8 in Miami.
Are you keeping up with the data and science that are driving the profession? The panelists who will be highlighting the critical importance of adult learning principles and certification of knowledge to career training insights on March 8 in Miami are: Donna Holder, PharmD, Executive Director, Global Field Medical Center of Excellence (CoE) at Merck, Stephen Valerio, MS, CMP, AstraZeneca Senior Director of Oncology Medical Training, Urvashi Vashee, PharmD, Team Lead Director, Global Scientific Training Oncology at Merck & Co, and Danielle C. Heuer, Director of WD Communications.
Ralph Rewers, PharmD, AbbVie’s Global Head, Field Medical Excellence pulled together a group of experts who will discuss the differences in the types of Field Medical that they’re looking to hire. This panel at the Field Medical session on March 8 in Miami includes Nancy Ortiz, PharmD, Executive Director, GMA & Field Medical at Stonebridge Biopharma, Steve McLaughlin, Regional Director, US Rare Disease Field Based MSLs, Sanofi Genzyme and Brooke M. Kim, RN, BSN, MSM who serves as the AbbVie National Director, Oncology Field Medical. The podcast will highlight topics to be discussed, such as rotational assignments, career ladders, and internal and external engagements 
Change is the only constant in the MSL role. Panelists at the session of the March 8 Field Medical Program in Miami will prepare attendees by discussing influences on the MSL role, the rationale for emerging Field Medical roles, and key skill sets to ensure success. Speaking will be: John Pracyk, MD, PhD, MBA, DePuy Synthes – Spine, Johnson & Johnson Medical Devices Companies, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Chris Brock, PharmD, Field Based Medical Affairs Head, Respiratory at GlaxoSmithKline, Joseph Medicis, PharmD Executive Director and Head of Medical Affairs at Allena Pharmaceuticals, Michelle Powell, PharmD, Director, Field Medical Excellence, Astellas Pharma Global Development and Kyle Kennedy, VP, Customer Strategy at The Medical Affairs Company.
Hosts John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, Depuy Synthes - Spine | Johnson & Johnson Medical Devices Companies and Marc Rubinstein, MD, Medical Director at Instrumentation Laboratory, welcome panelists Huub Kreuwel PhD, Vice President of Scientific and Medical Affairs at Octapharma, and Sean Lilienfeld MBBCh, MMEd(Neuro), FCP (Neuro), FAAN, a neurologist by training, and currently Vice President of Global Medical Affairs Clinical Operations, Pre-Clinical Research, and Clinical Strategy at Boston Scientific, two professionals who have successfully transitioned careers between MedTech and Pharma, and reciprocally, Pharma and MedTech.
If you’re considering a career transition, asking: “What’s in it for me?” is just as important as “What’s in it for the company?” During this podcast, Dr. Rubinstein asks the panelists, Dr. Sean Lilienfeld and Huub Kreuwel, why they considered making the change from one area to another. The potential for expanding your skillsets is an important consideration but it is not the only one.
While there are similarities in decision making between Pharma and MedTech, it can be difficult to get face time with physicians but is still relatively easy to get face time with surgeons particularly when the medical technology is more complex. Asking what success looks like to the patient is a critical element in a successful career transition.
Do you possess the ability to empathize, but also the business acumen to understand your audience? MA professionals interact with a variety of stakeholders, so you must possess the skills necessary to be relatable and to present information in a meaningful way to a wide audience. 
Teams are traditionally smaller in MedTech than in Pharma. In MedTech companies, the MA professional may be asked to manage smaller teams and broader areas of responsibilities. This may be the case if you work for a smaller Pharma company, but larger Pharma companies may require more focused responsibilities. 
What does it take to go from an external deep subject matter expert to an internal medical expert? Specializing in one area may limit your ability to transition from one therapeutic area to another; making this adjustment requires the ability to take a risk, the skills to gain trust, and comfort with admitting the limitations of your skill sets.  
Host John Pracyk, MD, PhD, MBA, Worldwide Integrated Leader, Medical Affairs, Pre-Clinical & Clinical Research, DePuy Synthes - Spine | Johnson & Johnson Medical Devices Companies welcomes Philip Desjardins, JD, Vice President, Global Regulatory Affairs Spine and Medical Device Regulatory Policy, DePuy Synthes | Johnson & Johnson Medical Devices Companies, and Drilon Saliu, PharmD, MBA, Head, Medical, Clinical and HEOR, Connected Care, Philips, to share insights into the importance of compliance with the new European Device Medical Regulation (EUMDR), including key deadlines for compliance. 
Cerise James, MD, moderates this podcast presentation by the MAPS Evidence Generation Focus Area Working Group in which Neil Belson, JD, discusses Real World Evidence and its impact. The podcast objectives are: To define Real World Evidence, and to demonstrate RWE and its impact to Biotech/Pharma.Mr. Belson will address a variety of topics including: The significance of Real World Evidence for the pharmaceutical and medical device industry; and, how the FDA views Real World Evidence. This is the first podcast in a series.
In this first of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Contributions Medical Affairs Makes to Asset Strategic Plans; and Time Horizon, Refreshing, and Resourcing of a Medical Affairs Plan. Panelists are: Ed Gudaitis, MBA, President & CEO Acerus Pharma Keith Johns, MBA, VP, Global Marketing and Alliance Management, Eli Lilly & Co; Maria Rivas, MD, Chief Medical Officer, EMD Serono/Merck KGaA 
loading
Comments 
Download from Google Play
Download from App Store